| NCT02638350 |
Performance Evaluation of Clinical Ultrasound in Management of Acute Pulmonary Edema in Elderly Patient |
https://ClinicalTrials.gov/show/NCT02638350 |
Completed |
University Hospital, Toulouse |
2019-03-21 |
| NCT02571972 |
Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. |
https://ClinicalTrials.gov/show/NCT02571972 |
Completed |
Wills Eye |
2015-09-30 |
| NCT02348918 |
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02348918 |
Completed |
Allegro Ophthalmics, LLC |
2017-05-16 |
| NCT03386019 |
The Efficacy of Lymphatic Massage on Lower Extremity Edema and Performance After Treadmill Exercise in Sprinter Compare to Static Stretching and Cold Water Immersion |
https://ClinicalTrials.gov/show/NCT03386019 |
Completed |
National Taiwan University Hospital |
2017-11-28 |
| NCT03405376 |
Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT03405376 |
Recruiting |
Yeungnam University College of Medicine |
2019-03-31 |
| NCT01651156 |
Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema |
https://ClinicalTrials.gov/show/NCT01651156 |
Completed |
Otsuka Beijing Research Institute |
2013-07-31 |
| NCT01120899 |
A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01120899 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-08-31 |
| NCT03341676 |
Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE) |
https://ClinicalTrials.gov/show/NCT03341676 |
Recruiting |
University Hospitals Coventry and Warwickshire NHS Trust |
2020-03-04 |
| NCT03329989 |
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women |
https://ClinicalTrials.gov/show/NCT03329989 |
Completed |
Endo Pharmaceuticals |
2018-09-05 |
| NCT03328715 |
iOCT for Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03328715 |
Recruiting |
Vienna Institute for Research in Ocular Surgery |
2020-09-01 |
| NCT03323580 |
Effects of Intraoperative GDFT on the Postoperative Brain Edema |
https://ClinicalTrials.gov/show/NCT03323580 |
Recruiting |
Beijing Tiantan Hospital |
2022-10-31 |
| NCT03321513 |
DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME |
https://ClinicalTrials.gov/show/NCT03321513 |
Active, not recruiting |
Jaeb Center for Health Research |
2021-12-20 |
| NCT03211741 |
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema |
https://ClinicalTrials.gov/show/NCT03211741 |
Recruiting |
University Hospital, Ghent |
2021-01-01 |
| NCT03197480 |
Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME |
https://ClinicalTrials.gov/show/NCT03197480 |
Recruiting |
Singapore National Eye Centre |
2020-12-31 |
| NCT03179813 |
Topical Hydrocortisone for Pain and Edema Control After Third Molar Surgery |
https://ClinicalTrials.gov/show/NCT03179813 |
Completed |
University of Sao Paulo |
2018-01-03 |
| NCT03161652 |
Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03161652 |
Recruiting |
Universidad Nacional Autonoma de Mexico |
2022-05-31 |
| NCT03143192 |
Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser |
https://ClinicalTrials.gov/show/NCT03143192 |
Completed |
Toronto Retina Institute |
2019-05-09 |
| NCT03126786 |
Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03126786 |
Completed |
Clearside Biomedical, Inc. |
2018-04-17 |
| NCT03108352 |
Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT03108352 |
Recruiting |
Chengdu Kanghong Biotech Co., Ltd. |
2019-12-31 |
| NCT02308644 |
Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study |
https://ClinicalTrials.gov/show/NCT02308644 |
Completed |
University of Sao Paulo |
2011-12-31 |
| NCT03093701 |
TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT03093701 |
Active, not recruiting |
Taiwan Liposome Company |
2020-12-31 |
| NCT03079453 |
An Approach to Reduce Uvula Edema After Tonsillectomy |
https://ClinicalTrials.gov/show/NCT03079453 |
Completed |
Bezmialem Vakif University |
2019-04-01 |
| NCT03071068 |
A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME) |
https://ClinicalTrials.gov/show/NCT03071068 |
Completed |
ThromboGenics |
2018-04-30 |
| NCT03069521 |
Study to Evaluate the Safety of the EndoArtâ„¢ for Treatment of Subjects Suffering From Corneal Edema |
https://ClinicalTrials.gov/show/NCT03069521 |
Recruiting |
Eye-yon Medical |
2019-12-31 |
| NCT03056092 |
Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab |
https://ClinicalTrials.gov/show/NCT03056092 |
Recruiting |
St. Michael’s Hospital, Toronto |
2020-02-28 |
| NCT03056079 |
Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept |
https://ClinicalTrials.gov/show/NCT03056079 |
Recruiting |
St. Michael’s Hospital, Toronto |
2020-02-28 |
| NCT02262260 |
Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME |
https://ClinicalTrials.gov/show/NCT02262260 |
Completed |
Novartis |
2017-09-12 |
| NCT03000283 |
Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study |
https://ClinicalTrials.gov/show/NCT03000283 |
Completed |
Allina Health System |
2019-02-12 |
| NCT02985619 |
Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02985619 |
Completed |
University of Sao Paulo |
2017-04-14 |
| NCT02977572 |
Non-invasive Ventilation Versus Continuous Positive Airway Pressure in Cardiogenic Pulmonary Edema |
https://ClinicalTrials.gov/show/NCT02977572 |
Completed |
Hospital General Universitario de Castellón |
2010-12-31 |
| NCT02953938 |
Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety |
https://ClinicalTrials.gov/show/NCT02953938 |
Completed |
Novartis |
2018-12-28 |
| NCT02949024 |
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02949024 |
Completed |
Clearside Biomedical, Inc. |
2017-04-12 |
| NCT02942160 |
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) |
https://ClinicalTrials.gov/show/NCT02942160 |
Completed |
Endo Pharmaceuticals |
2018-06-14 |
| NCT02914613 |
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT02914613 |
Completed |
SciFluor Life Sciences, Inc. |
2017-05-16 |
| NCT02901379 |
Effect of 80-mg Atorvastatin on Myocardial Edema |
https://ClinicalTrials.gov/show/NCT02901379 |
Completed |
National Cardiovascular Center Harapan Kita Hospital Indonesia |
2018-08-31 |
| NCT02867735 |
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema |
https://ClinicalTrials.gov/show/NCT02867735 |
Completed |
Novartis |
2018-02-15 |
| NCT02864953 |
Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction |
https://ClinicalTrials.gov/show/NCT02864953 |
Recruiting |
Biogen |
2021-03-31 |
| NCT02856698 |
MIdazolam Versus MOrphine in Acute Pulmonary Edema (MIMO Trial) |
https://ClinicalTrials.gov/show/NCT02856698 |
Recruiting |
Hospital Universitario de Canarias |
2020-12-31 |
| NCT01529385 |
Mild Compression Sock for Control of Lower Extremity Edema in Individuals With Diabetes |
https://ClinicalTrials.gov/show/NCT01529385 |
Completed |
Rosalind Franklin University of Medicine and Science |
2014-09-30 |
| NCT02818998 |
Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT02818998 |
Completed |
Bayer |
2018-11-13 |
| NCT02796183 |
The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02796183 |
Completed |
Neon Hospital |
2016-04-30 |
| NCT02788877 |
Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study) |
https://ClinicalTrials.gov/show/NCT02788877 |
Active, not recruiting |
Pusan National University Hospital |
2019-09-30 |
| NCT01486238 |
Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study |
https://ClinicalTrials.gov/show/NCT01486238 |
Completed |
Valley Retina Institute |
2011-07-31 |
| NCT01472510 |
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy |
https://ClinicalTrials.gov/show/NCT01472510 |
Completed |
Vitreo-Retinal Associates, PC |
2013-07-31 |
| NCT02734407 |
Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02734407 |
Completed |
Retina-Vitreous Associates Medical Group |
2017-09-27 |
| NCT02732951 |
Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02732951 |
Completed |
Boehringer Ingelheim |
2017-10-23 |
| NCT02724644 |
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) |
https://ClinicalTrials.gov/show/NCT02724644 |
Completed |
Endo Pharmaceuticals |
2016-09-30 |
| NCT02712008 |
Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02712008 |
Completed |
Regeneron Pharmaceuticals |
2017-07-10 |
| NCT02698566 |
A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS) |
https://ClinicalTrials.gov/show/NCT02698566 |
Completed |
Genentech, Inc. |
2016-04-05 |
| NCT02663141 |
Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02663141 |
Completed |
Tehran University of Medical Sciences |
2016-06-30 |
| NCT02660151 |
Study of Using the Hyper-CLâ„¢ Lens (Hyper Osmotic Contact Lens) in Subjects Suffering From Corneal Edema |
https://ClinicalTrials.gov/show/NCT02660151 |
Completed |
Eye-yon Medical |
2018-10-31 |
| NCT02633852 |
Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02633852 |
Completed |
Hadassah Medical Organization |
2018-08-28 |
| NCT02627976 |
Breast Edema Compression Vest |
https://ClinicalTrials.gov/show/NCT02627976 |
Completed |
UMC Utrecht |
2018-01-31 |
| NCT02626585 |
The Effect of Postrhinoplasty Taping on Postoperative Edema and Nasal Draping |
https://ClinicalTrials.gov/show/NCT02626585 |
Completed |
Bezmialem Vakif University |
2015-06-30 |
| NCT02624765 |
FAST Therapy Trial of Fetal Tachyarrhythmia |
https://ClinicalTrials.gov/show/NCT02624765 |
Recruiting |
The Hospital for Sick Children |
2021-03-31 |
| NCT02623426 |
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial |
https://ClinicalTrials.gov/show/NCT02623426 |
Active, not recruiting |
JHSPH Center for Clinical Trials |
2021-01-31 |
| NCT02614937 |
Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT02614937 |
Completed |
Ohr Pharmaceutical Inc. |
2014-12-31 |
| NCT02609165 |
Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema |
https://ClinicalTrials.gov/show/NCT02609165 |
Completed |
Ospedale San Raffaele |
2017-02-28 |
| NCT02559180 |
Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab |
https://ClinicalTrials.gov/show/NCT02559180 |
Recruiting |
The Cleveland Clinic |
2020-11-30 |
| NCT02556723 |
Intravitreal Injections of Ziv-aflibercept for Macular Diseases |
https://ClinicalTrials.gov/show/NCT02556723 |
Completed |
Retina Clinic, Sao Paulo, Brazil |
2015-09-30 |
| NCT03397264 |
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03397264 |
Active, not recruiting |
Opthea Limited |
2020-05-31 |
| NCT02554747 |
Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa |
https://ClinicalTrials.gov/show/NCT02554747 |
Completed |
Odense University Hospital |
2017-12-31 |
| NCT02503540 |
Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO |
https://ClinicalTrials.gov/show/NCT02503540 |
Completed |
The Cleveland Clinic |
2018-02-06 |
| NCT02472366 |
A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy |
https://ClinicalTrials.gov/show/NCT02472366 |
Completed |
Alimera Sciences |
2015-03-31 |
| NCT02471651 |
Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02471651 |
Completed |
California Retina Consultants |
2018-10-24 |
| NCT02457884 |
Effectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT02457884 |
Completed |
The Hong Kong Polytechnic University |
2018-03-31 |
| NCT02448446 |
The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates |
https://ClinicalTrials.gov/show/NCT02448446 |
Completed |
South Coast Retina Center; Carson, McBeath, Boswell, Inc. |
2018-05-31 |
| NCT02443012 |
Topical Nepafenac as Supplement for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02443012 |
Completed |
Universiti Sains Malaysia |
2014-08-31 |
| NCT02441907 |
Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02441907 |
Completed |
St. Michael’s Hospital, Toronto |
2018-08-31 |
| NCT02427880 |
Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema |
https://ClinicalTrials.gov/show/NCT02427880 |
Completed |
Shiraz University of Medical Sciences |
2015-06-30 |
| NCT02406157 |
577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02406157 |
Completed |
Sun Yat-sen University |
2018-07-31 |
| NCT02403128 |
Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms |
https://ClinicalTrials.gov/show/NCT02403128 |
Active, not recruiting |
Illinois Retina and Eye Associates |
2020-02-29 |
| NCT02392364 |
Variable Interval Versus Set Interval Aflibercept for DME |
https://ClinicalTrials.gov/show/NCT02392364 |
Completed |
California Retina Consultants |
2018-11-15 |
| NCT02374060 |
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial |
https://ClinicalTrials.gov/show/NCT02374060 |
Completed |
JHSPH Center for Clinical Trials |
2017-08-30 |
| NCT01613716 |
Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study) |
https://ClinicalTrials.gov/show/NCT01613716 |
Completed |
The Cleveland Clinic |
2016-12-31 |
| NCT01627249 |
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01627249 |
Completed |
Jaeb Center for Health Research |
2014-10-31 |
| NCT02359526 |
A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients |
https://ClinicalTrials.gov/show/NCT02359526 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2016-03-31 |
| NCT02316210 |
Optimization of Onpulse Technology for Patients With Post Surgical or Vascular Oedema |
https://ClinicalTrials.gov/show/NCT02316210 |
Completed |
Firstkind Ltd |
2015-09-30 |
| NCT02314299 |
A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT02314299 |
Completed |
Stealth BioTherapeutics Inc. |
2015-05-31 |
| NCT02310295 |
Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02310295 |
Completed |
University of Sao Paulo |
2011-12-31 |
| NCT02303184 |
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO |
https://ClinicalTrials.gov/show/NCT02303184 |
Completed |
Clearside Biomedical, Inc. |
2016-03-31 |
| NCT02294656 |
Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide |
https://ClinicalTrials.gov/show/NCT02294656 |
Completed |
Soll Eye |
2018-09-30 |
| NCT02259088 |
A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients |
https://ClinicalTrials.gov/show/NCT02259088 |
Completed |
Novartis |
2017-01-17 |
| NCT02255032 |
Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis |
https://ClinicalTrials.gov/show/NCT02255032 |
Completed |
Clearside Biomedical, Inc. |
2015-12-31 |
| NCT02245516 |
Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02245516 |
Completed |
Kala Pharmaceuticals, Inc. |
2014-12-31 |
| NCT02221453 |
Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide |
https://ClinicalTrials.gov/show/NCT02221453 |
Completed |
St. Michael’s Hospital, Toronto |
2016-12-31 |
| NCT02193113 |
A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME |
https://ClinicalTrials.gov/show/NCT02193113 |
Completed |
KalVista Pharmaceuticals, Ltd. |
2015-06-04 |
| NCT02186119 |
A Study of Abicipar Pegol in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02186119 |
Completed |
Allergan |
2015-06-30 |
| NCT02131350 |
Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema |
https://ClinicalTrials.gov/show/NCT02131350 |
Completed |
Shinshu University |
2017-03-31 |
| NCT02121262 |
A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02121262 |
Completed |
Allergan |
2019-10-09 |
| NCT02103283 |
A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT02103283 |
Completed |
River Vision Development Corporation |
2016-08-31 |
| NCT02084576 |
Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification |
https://ClinicalTrials.gov/show/NCT02084576 |
Completed |
Hospital Oftalmologico de Brasilia |
2013-08-31 |
| NCT03973138 |
Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab |
https://ClinicalTrials.gov/show/NCT03973138 |
Recruiting |
Sun Yat-sen University |
2020-01-01 |
| NCT01348269 |
Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome |
https://ClinicalTrials.gov/show/NCT01348269 |
Completed |
Wuerzburg University Hospital |
2015-08-26 |
| NCT01315275 |
A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema |
https://ClinicalTrials.gov/show/NCT01315275 |
Completed |
Novartis |
2012-08-31 |
| NCT01309451 |
Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01309451 |
Completed |
Maturi, Raj K., M.D., P.C. |
2013-04-30 |
| NCT01304706 |
Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study |
https://ClinicalTrials.gov/show/NCT01304706 |
Completed |
Alimera Sciences |
2013-11-30 |
| NCT01298076 |
Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT01298076 |
Completed |
University of Sydney |
2014-09-30 |
| NCT01297569 |
Ranibizumab “Treat and Extend” in Diabetic Macular Edma |
https://ClinicalTrials.gov/show/NCT01297569 |
Completed |
Novartis |
2012-11-30 |
| NCT01292798 |
Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab |
https://ClinicalTrials.gov/show/NCT01292798 |
Completed |
California Retina Consultants |
2013-04-30 |
| NCT01284478 |
Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01284478 |
Completed |
Northern California Retina Vitreous Associates |
2012-10-31 |
| NCT01277302 |
A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01277302 |
Completed |
Genentech, Inc. |
2012-10-31 |
| NCT02055872 |
Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT02055872 |
Completed |
Hamilton Health Sciences Corporation |
2016-10-31 |
| NCT02050828 |
The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02050828 |
Completed |
Aerpio Therapeutics |
2015-04-30 |
| NCT02036424 |
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02036424 |
Completed |
Maturi, Raj K., M.D., P.C. |
2015-08-31 |
| NCT02006147 |
Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO |
https://ClinicalTrials.gov/show/NCT02006147 |
Active, not recruiting |
Taiwan Liposome Company |
2020-12-31 |
| NCT02002403 |
Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02002403 |
Completed |
St. Michael’s Hospital, Toronto |
2012-04-30 |
| NCT01997164 |
Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular (“Wet”) Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01997164 |
Completed |
Regeneron Pharmaceuticals |
2015-10-31 |
| NCT01987986 |
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy |
https://ClinicalTrials.gov/show/NCT01987986 |
Completed |
Endo Pharmaceuticals |
2014-08-31 |
| NCT01982435 |
Safety and Efficacy of Ranibizumab for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01982435 |
Completed |
The Cleveland Clinic |
2016-05-26 |
| NCT01976338 |
Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) |
https://ClinicalTrials.gov/show/NCT01976338 |
Completed |
Novartis |
2016-03-28 |
| NCT01939691 |
Macular Edema Nepafenac vs. Difluprednate Uveitis Trial |
https://ClinicalTrials.gov/show/NCT01939691 |
Recruiting |
University of California, San Francisco |
2020-11-30 |
| NCT01934556 |
A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01934556 |
Completed |
Palmetto Retina Center, LLC |
2017-04-30 |
| NCT01909791 |
Treatment for CI-DME in Eyes With Very Good VA Study |
https://ClinicalTrials.gov/show/NCT01909791 |
Completed |
Jaeb Center for Health Research |
2018-09-11 |
| NCT01903720 |
A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01903720 |
Completed |
Allergan |
2014-09-24 |
| NCT01892163 |
Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone |
https://ClinicalTrials.gov/show/NCT01892163 |
Completed |
Moorfields Eye Hospital NHS Foundation Trust |
2014-12-31 |
| NCT01887379 |
Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions) |
https://ClinicalTrials.gov/show/NCT01887379 |
Completed |
LTS Lohmann Therapie-Systeme AG |
2013-08-31 |
| NCT01875783 |
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits |
https://ClinicalTrials.gov/show/NCT01875783 |
Completed |
Joslin Diabetes Center |
2015-05-14 |
| NCT01870440 |
TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema |
https://ClinicalTrials.gov/show/NCT01870440 |
Completed |
Northern California Retina Vitreous Associates |
2015-02-28 |
| NCT01870427 |
NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions |
https://ClinicalTrials.gov/show/NCT01870427 |
Completed |
Northern California Retina Vitreous Associates |
2015-08-31 |
| NCT01860820 |
The Effect of Neuromuscular Stimulation on Post-Transplant Leg Edema |
https://ClinicalTrials.gov/show/NCT01860820 |
Enrolling by invitation |
Lawson Health Research Institute |
2019-09-30 |
| NCT01823965 |
Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment |
https://ClinicalTrials.gov/show/NCT01823965 |
Completed |
Poitiers University Hospital |
2014-07-31 |
| NCT01821677 |
AP-05-002 A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug)in the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01821677 |
Completed |
Ampio Pharmaceuticals. Inc. |
2014-06-30 |
| NCT01823081 |
Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01823081 |
Completed |
Shahid Beheshti University of Medical Sciences |
2013-06-30 |
| NCT01787669 |
Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT01787669 |
Completed |
University of Sydney |
2017-01-31 |
| NCT01774474 |
PRevention of Macular EDema After Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01774474 |
Completed |
Maastricht University Medical Center |
2016-11-04 |
| NCT03511898 |
A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT03511898 |
Completed |
Oxurion |
2019-05-22 |
| NCT01732614 |
Topcon Endpoint Management |
https://ClinicalTrials.gov/show/NCT01732614 |
Completed |
Retinal Consultants of Arizona |
2013-11-30 |
| NCT01702441 |
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01702441 |
Completed |
Aerpio Therapeutics |
2013-09-30 |
| NCT01698749 |
Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01698749 |
Completed |
Postgraduate Institute of Medical Education and Research |
2012-01-31 |
| NCT01684202 |
A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2) |
https://ClinicalTrials.gov/show/NCT01684202 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2013-12-31 |
| NCT01662518 |
DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT01662518 |
Completed |
Centro de Pesquisa Rubens Siqueira |
2016-01-31 |
| NCT01661946 |
Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye |
https://ClinicalTrials.gov/show/NCT01661946 |
Completed |
Queen’s University |
2013-07-31 |
| NCT01660802 |
Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT01660802 |
Completed |
Allergan |
2014-03-31 |
| NCT03927690 |
Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03927690 |
Recruiting |
Novartis |
2021-02-09 |
| NCT01618448 |
Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure |
https://ClinicalTrials.gov/show/NCT01618448 |
Completed |
Taiwan Otsuka Pharm. Co., Ltd |
2014-05-31 |
| NCT01610557 |
Ranibizumab and Bevacizumab for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01610557 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-02-28 |
| NCT00799227 |
Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00799227 |
Completed |
Allergan |
2009-12-01 |
| NCT02556424 |
Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema |
https://ClinicalTrials.gov/show/NCT02556424 |
Recruiting |
Nantes University Hospital |
2020-10-31 |
| NCT01571232 |
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01571232 |
Completed |
Retina Macula Institute |
2014-02-28 |
| NCT01564108 |
The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema |
https://ClinicalTrials.gov/show/NCT01564108 |
Completed |
Moorfields Eye Hospital NHS Foundation Trust |
2014-06-30 |
| NCT01546402 |
Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01546402 |
Completed |
Postgraduate Institute of Medical Education and Research |
2012-11-30 |
| NCT01535261 |
Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01535261 |
Completed |
Novartis |
2015-03-31 |
| NCT01518907 |
The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) |
https://ClinicalTrials.gov/show/NCT01518907 |
Completed |
Endo Pharmaceuticals |
2012-12-31 |
| NCT01512966 |
Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema) |
https://ClinicalTrials.gov/show/NCT01512966 |
Completed |
Bayer |
2013-09-30 |
| NCT01512901 |
Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI) |
https://ClinicalTrials.gov/show/NCT01512901 |
Completed |
Santen Pharmaceutical Co., Ltd. |
NA |
| NCT01492400 |
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01492400 |
Completed |
Allergan |
2014-02-13 |
| NCT01476449 |
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema |
https://ClinicalTrials.gov/show/NCT01476449 |
Completed |
Retina Vitreous Associates of Florida |
2016-09-30 |
| NCT01473251 |
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01473251 |
Completed |
Vitreo-Retinal Associates, Michigan |
2014-04-30 |
| NCT01445899 |
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01445899 |
Completed |
Quark Pharmaceuticals |
2013-11-30 |
| NCT01442064 |
An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2) |
https://ClinicalTrials.gov/show/NCT01442064 |
Completed |
Genentech, Inc. |
2010-07-31 |
| NCT01441102 |
Dextromethorphan for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01441102 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-06-30 |
| NCT01428388 |
Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01428388 |
Completed |
Barnes Retina Institute |
2015-10-31 |
| NCT01411254 |
Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA) |
https://ClinicalTrials.gov/show/NCT01411254 |
Completed |
Santen Pharmaceutical Co., Ltd. |
NA |
| NCT01396083 |
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT01396083 |
Completed |
Novartis |
2014-01-31 |
| NCT01396057 |
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) |
https://ClinicalTrials.gov/show/NCT01396057 |
Completed |
Novartis |
2013-06-30 |
| NCT01395069 |
Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery |
https://ClinicalTrials.gov/show/NCT01395069 |
Completed |
Queen’s University |
2011-05-31 |
| NCT01389089 |
Effective Treatment of Posttraumatic and Postoperative Edema |
https://ClinicalTrials.gov/show/NCT01389089 |
Completed |
Luzerner Kantonsspital |
2009-01-31 |
| NCT01363440 |
Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01363440 |
Completed |
Regeneron Pharmaceuticals |
2013-01-31 |
| NCT01355692 |
Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01355692 |
Completed |
Lumenis Ltd. |
2015-06-30 |
| NCT01342159 |
Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01342159 |
Completed |
Hallym University Medical Center |
2010-02-28 |
| NCT01331681 |
Intravitreal Aflibercept Injection in Vision Impairment Due to DME |
https://ClinicalTrials.gov/show/NCT01331681 |
Completed |
Bayer |
2013-06-30 |
| NCT01331005 |
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01331005 |
Completed |
Jaeb Center for Health Research |
2013-12-31 |
| NCT03699046 |
Evaluating the Effectiveness of Subchondroplasty for Treating Bone Marrow Lesions of the Knee |
https://ClinicalTrials.gov/show/NCT03699046 |
Recruiting |
University of Calgary |
2021-03-31 |
| NCT01324869 |
Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01324869 |
Completed |
Chengdu Kanghong Biotech Co., Ltd. |
2012-02-29 |
| NCT01319487 |
Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01319487 |
Completed |
Fovea Pharmaceuticals SA |
2012-03-31 |
| NCT04418427 |
ADVM-022 Intravitreal Gene Therapy for DME |
https://ClinicalTrials.gov/show/NCT04418427 |
Recruiting |
Adverum Biotechnologies, Inc. |
2021-05-31 |
| NCT04411693 |
Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT04411693 |
Recruiting |
The Cleveland Clinic |
2021-06-01 |
| NCT04359771 |
Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT04359771 |
Completed |
Cairo University |
2018-09-25 |
| NCT04332133 |
Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT04332133 |
Completed |
Minia University |
2019-03-31 |
| NCT04296838 |
Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF |
https://ClinicalTrials.gov/show/NCT04296838 |
Recruiting |
Peking Union Medical College Hospital |
2020-05-31 |
| NCT04215692 |
Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients |
https://ClinicalTrials.gov/show/NCT04215692 |
Recruiting |
Instituto Mexicano del Seguro Social |
2020-06-01 |
| NCT04191629 |
Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema |
https://ClinicalTrials.gov/show/NCT04191629 |
Recruiting |
Asociación para Evitar la Ceguera en México |
2020-12-31 |
| NCT04187443 |
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema |
https://ClinicalTrials.gov/show/NCT04187443 |
Recruiting |
MingSight Pharmaceuticals Pty Limited |
2021-08-18 |
| NCT04164927 |
The Effects of Manual Lymphatic Drainage and Kinesiotaping on Lower Extremity Edema |
https://ClinicalTrials.gov/show/NCT04164927 |
Completed |
Hacettepe University |
2015-08-30 |
| NCT04151407 |
The Study of Drug 601 in Patients With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT04151407 |
Recruiting |
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. |
2020-12-31 |
| NCT04148950 |
Effects of Kinesio Taping Method on Functional Capacity and Quality of Life in Patients With Chronic Venous Disease |
https://ClinicalTrials.gov/show/NCT04148950 |
Completed |
Istanbul University |
2015-05-31 |
| NCT04125394 |
Efficacy and Tolerance of Hypertonic Sodium Chloride (NaCl 5%) Eye Drops Without Preservatives in Corneal Edema |
https://ClinicalTrials.gov/show/NCT04125394 |
Recruiting |
Tiedra Farmacéutica SL |
2020-05-31 |
| NCT04120636 |
Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole |
https://ClinicalTrials.gov/show/NCT04120636 |
Recruiting |
Targeted Therapy Technologies, LLC |
2020-10-30 |
| NCT04120311 |
Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole |
https://ClinicalTrials.gov/show/NCT04120311 |
Recruiting |
Targeted Therapy Technologies, LLC |
2020-08-25 |
| NCT04119297 |
Effects of Cold Application and Heparinoid on Periorbital Edema and Ecchymosis |
https://ClinicalTrials.gov/show/NCT04119297 |
Completed |
Necmettin Erbakan University |
2011-07-01 |
| NCT04108156 |
This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Participants With Diabetic Macular Edema Compared With Intravitreal Ranibizumab |
https://ClinicalTrials.gov/show/NCT04108156 |
Recruiting |
Hoffmann-La Roche |
2021-10-31 |
| NCT04089605 |
Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT04089605 |
Completed |
Far Eastern Memorial Hospital |
2018-11-01 |
| NCT04088630 |
Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage |
https://ClinicalTrials.gov/show/NCT04088630 |
Recruiting |
Wake Forest University Health Sciences |
2022-04-30 |
| NCT04087746 |
Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT04087746 |
Completed |
Minia University |
2019-01-31 |
| NCT04085341 |
A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT04085341 |
Active, not recruiting |
Graybug Vision |
2020-04-30 |
| NCT04063358 |
Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery |
https://ClinicalTrials.gov/show/NCT04063358 |
Recruiting |
Second Military Medical University |
2021-08-31 |
| NCT02699450 |
A Study of Faricimab (RO6867461) in Participants With Center-involving Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02699450 |
Completed |
Hoffmann-La Roche |
2017-09-15 |
| NCT04014556 |
Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT04014556 |
Completed |
University of Alexandria |
2018-10-01 |
| NCT04014088 |
Helmet CPAP vs Facemask CPAP in ACPE (hCPAP vs fCPAP) |
https://ClinicalTrials.gov/show/NCT04014088 |
Completed |
Hospital Raja Permaisuri Bainun |
2017-12-31 |
| NCT04005430 |
A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema |
https://ClinicalTrials.gov/show/NCT04005430 |
Recruiting |
Targeted Therapy Technologies, LLC |
2020-06-15 |
| NCT04005092 |
Helmet CPAP Versus HFNC in Acute Cardiogenic Pulmonary Edema |
https://ClinicalTrials.gov/show/NCT04005092 |
Completed |
Hospital Raja Permaisuri Bainun |
2018-08-31 |
| NCT03984110 |
The Use of a Combination of Ozurdex and Eylea Versus Eylea Monotherapy for Diabetic Macular Edema: A Prospective, Comparative Trial (COED Trial) |
https://ClinicalTrials.gov/show/NCT03984110 |
Recruiting |
Texas Retina Associates |
2020-06-15 |
| NCT03975088 |
Sub-macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03975088 |
Completed |
University of Alexandria |
2017-12-31 |
| NCT03974425 |
One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab |
https://ClinicalTrials.gov/show/NCT03974425 |
Completed |
University of Alexandria |
2017-04-01 |
| NCT03956797 |
Long Term Safety of Cooling Anesthesia for Intravitreal Injection |
https://ClinicalTrials.gov/show/NCT03956797 |
Recruiting |
Recens Medical, Inc. |
2020-05-30 |
| NCT03953807 |
A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated |
https://ClinicalTrials.gov/show/NCT03953807 |
Recruiting |
Allergan |
2021-05-31 |
| NCT03936751 |
Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: CPAP-CARE STUDY. |
https://ClinicalTrials.gov/show/NCT03936751 |
Recruiting |
University of Sao Paulo |
2020-04-01 |
| NCT03917472 |
Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03917472 |
Active, not recruiting |
Novartis |
2021-07-30 |
| NCT03908723 |
Treatment of Macular Edema Caused by Leber’s Miliary Aneurysms Using Intravitreal Aflibercept and Peripheral Laser Photocoagulation |
https://ClinicalTrials.gov/show/NCT03908723 |
Recruiting |
Alexandria University |
2021-03-29 |
| NCT03867305 |
Evaluation of the Action of MOBIDERM® on Periarticular Edema After Total Knee Prosthesis - Randomized Controlled |
https://ClinicalTrials.gov/show/NCT03867305 |
Recruiting |
Centre Hospitalier Universitaire de NÄ«mes |
2020-07-31 |
| NCT03866746 |
Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03866746 |
Completed |
Al Hadi Hospital |
2017-06-21 |
| NCT03866473 |
A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03866473 |
Active, not recruiting |
Jaeb Center for Health Research |
2020-04-21 |
| NCT03835884 |
A Study Assessing AR-13503 Implant Alone and in Combination With Aflibercept in Subjects With nAMD or DME |
https://ClinicalTrials.gov/show/NCT03835884 |
Active, not recruiting |
Aerie Pharmaceuticals |
2021-09-30 |
| NCT03832179 |
Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification |
https://ClinicalTrials.gov/show/NCT03832179 |
Recruiting |
Bay Area Retina Associates |
2020-06-01 |
| NCT01698788 |
Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01698788 |
Completed |
Postgraduate Institute of Medical Education and Research |
2011-12-31 |
| NCT03759860 |
Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03759860 |
Active, not recruiting |
LUTRONIC Corporation |
2019-07-30 |
| NCT03739593 |
Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT03739593 |
Active, not recruiting |
Aerie Pharmaceuticals |
2020-05-31 |
| NCT02368366 |
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI |
https://ClinicalTrials.gov/show/NCT02368366 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2017-11-30 |
| NCT03715387 |
Tacrolimus for Malar Edema |
https://ClinicalTrials.gov/show/NCT03715387 |
Recruiting |
University of British Columbia |
2019-07-01 |
| NCT03690167 |
Investigation of the Effects of CGF and A-PRF on Pain, Edema and Trismus After Impacted Lower Third Molar Surgery |
https://ClinicalTrials.gov/show/NCT03690167 |
Completed |
T.C. ORDU ÃœNÄ°VERSÄ°TESÄ° |
2019-03-01 |
| NCT03675685 |
Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP |
https://ClinicalTrials.gov/show/NCT03675685 |
Completed |
Endo Pharmaceuticals |
2018-11-01 |
| NCT03666923 |
A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT03666923 |
Completed |
Oxurion |
2019-11-20 |
| NCT03660345 |
Pars Plana Vitrectomy With Internal Limiting Membrane Peeling Versus Intravitreal Ziv-Aflibercept for Treatment-Naïve Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03660345 |
Recruiting |
Rush Eye Associates |
2020-09-04 |
| NCT03641144 |
Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03641144 |
Recruiting |
Sun Yat-sen University |
2019-07-31 |
| NCT03635814 |
The Study to YD312 Tablet in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03635814 |
Active, not recruiting |
YD Global Life Science Co., Ltd. |
2018-07-27 |
| NCT03632993 |
Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite) |
https://ClinicalTrials.gov/show/NCT03632993 |
Completed |
Endo Pharmaceuticals |
2019-01-24 |
| NCT03622593 |
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03622593 |
Enrolling by invitation |
Hoffmann-La Roche |
2020-09-30 |
| NCT03622580 |
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) |
https://ClinicalTrials.gov/show/NCT03622580 |
Active, not recruiting |
Hoffmann-La Roche |
2020-09-30 |
| NCT02302079 |
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT02302079 |
Completed |
Astellas Pharma Inc |
2016-08-12 |
| NCT03590444 |
Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser |
https://ClinicalTrials.gov/show/NCT03590444 |
Completed |
Hospital Hietzing |
2018-04-02 |
| NCT03546725 |
The Effect of Compression Stockings on Edema and Discomfort During Short Haul Flights |
https://ClinicalTrials.gov/show/NCT03546725 |
Completed |
Herlev and Gentofte Hospital |
2018-05-26 |
| NCT03533478 |
Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema |
https://ClinicalTrials.gov/show/NCT03533478 |
Completed |
Catalysis SL |
2018-12-01 |
| NCT03526549 |
Long-Term Study of EN3835 in Edematous Fibrosclerotic Panniculopathy (Cellulite) |
https://ClinicalTrials.gov/show/NCT03526549 |
Active, not recruiting |
Endo Pharmaceuticals |
2023-10-31 |
| NCT03519581 |
Micropulse for Suppression of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03519581 |
Recruiting |
University of California, Davis |
2020-12-31 |
| NCT03499223 |
A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME) |
https://ClinicalTrials.gov/show/NCT03499223 |
Completed |
Oxurion |
2019-07-18 |
| NCT03495765 |
To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT03495765 |
Completed |
Marsden Eye Specialists |
2017-01-01 |
| NCT03490409 |
Effect of Compression Therapy on Postoperative Swelling and Pain After Total Knee Arthroplasty |
https://ClinicalTrials.gov/show/NCT03490409 |
Completed |
Naestved Hospital |
2018-04-09 |
| NCT03481660 |
A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03481660 |
Active, not recruiting |
Novartis |
2020-07-15 |
| NCT03481634 |
Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03481634 |
Active, not recruiting |
Novartis |
2020-11-11 |
| NCT03466099 |
Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME) |
https://ClinicalTrials.gov/show/NCT03466099 |
Completed |
KalVista Pharmaceuticals, Ltd. |
2019-10-10 |
| NCT03453281 |
Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection |
https://ClinicalTrials.gov/show/NCT03453281 |
Completed |
Indonesia University |
2018-04-09 |
| NCT03446781 |
Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women |
https://ClinicalTrials.gov/show/NCT03446781 |
Completed |
Endo Pharmaceuticals |
2018-09-26 |
| NCT03438864 |
Acute Effects of Interferential Current on Edema, Pain and Muscle Strength in Patients With Distal Radius Fracture |
https://ClinicalTrials.gov/show/NCT03438864 |
Completed |
Ege University |
2017-12-07 |
| NCT03428750 |
Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women |
https://ClinicalTrials.gov/show/NCT03428750 |
Completed |
Endo Pharmaceuticals |
2018-09-26 |
| NCT03412760 |
Hydrops: Diagnosing & Redefining Outcomes With Precision Study |
https://ClinicalTrials.gov/show/NCT03412760 |
Recruiting |
University of California, San Francisco |
2025-11-30 |
| NCT01259609 |
Changes in Ciliary Body Thickness in Patients With Diabetic Macular Edema After Vitrectomy |
https://ClinicalTrials.gov/show/NCT01259609 |
Completed |
Seoul National University Hospital |
2010-04-30 |
| NCT01257815 |
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment |
https://ClinicalTrials.gov/show/NCT01257815 |
Completed |
Novartis |
2013-04-30 |
| NCT01244334 |
Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. |
https://ClinicalTrials.gov/show/NCT01244334 |
Completed |
Cincinnati Eye Institute Northern Kentucky |
2010-06-30 |
| NCT01231633 |
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT01231633 |
Completed |
Long Island Vitreoretinal Consultants |
2014-09-30 |
| NCT01219205 |
Major and Macular Branched Retinal Venous Occlusion |
https://ClinicalTrials.gov/show/NCT01219205 |
Completed |
Hallym University Medical Center |
2009-02-28 |
| NCT01202461 |
Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01202461 |
Completed |
Samsung Medical Center |
2010-08-31 |
| NCT01189461 |
Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01189461 |
Completed |
Pfizer |
2012-07-31 |
| NCT01171976 |
Efficacy and Safety of Ranibizumab in Two “Treat and Extend” Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT01171976 |
Completed |
Novartis |
2013-04-30 |
| NCT01208948 |
Clinical Trial on Alpha Lipoic Acid in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01208948 |
Completed |
Ludwig-Maximilians - University of Munich |
2005-04-30 |
| NCT01175070 |
Intravitreal Macugen for Ischaemic Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT01175070 |
Completed |
University of Oxford |
2013-03-31 |
| NCT01135914 |
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT01135914 |
Completed |
Novartis |
2013-03-31 |
| NCT01112085 |
MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2) |
https://ClinicalTrials.gov/show/NCT01112085 |
Completed |
Especialistas en Retina Medica y Quirurgica Grupo de Investigacion |
2014-01-31 |
| NCT01100307 |
A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT01100307 |
Completed |
Pfizer |
2012-08-31 |
| NCT01077401 |
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study |
https://ClinicalTrials.gov/show/NCT01077401 |
Completed |
Johns Hopkins University |
2012-03-31 |
| NCT01060969 |
Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness Prevention |
https://ClinicalTrials.gov/show/NCT01060969 |
Completed |
Sheba Medical Center |
2010-08-31 |
| NCT01030601 |
Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS) |
https://ClinicalTrials.gov/show/NCT01030601 |
Completed |
University Health Network, Toronto |
2011-01-31 |
| NCT01027650 |
Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT01027650 |
Completed |
Allergan |
2012-04-30 |
| NCT00997191 |
Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA) |
https://ClinicalTrials.gov/show/NCT00997191 |
Completed |
University of Sao Paulo |
2011-11-30 |
| NCT00994955 |
Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00994955 |
Completed |
University of Schleswig-Holstein |
2008-12-31 |
| NCT00989989 |
Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00989989 |
Completed |
Novartis |
2011-08-31 |
| NCT00943072 |
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT00943072 |
Completed |
Regeneron Pharmaceuticals |
2010-10-31 |
| NCT00912158 |
Non Invasive Mechanical Ventilation in Acute Cardiogenic Pulmonary Edema |
https://ClinicalTrials.gov/show/NCT00912158 |
Completed |
Assiut University |
2007-11-30 |
| NCT00900887 |
Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema |
https://ClinicalTrials.gov/show/NCT00900887 |
Completed |
Hospital Juarez de Mexico |
2015-03-31 |
| NCT00886808 |
Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00886808 |
Completed |
iCo Therapeutics Inc. |
2010-05-31 |
| NCT00874744 |
Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00874744 |
Completed |
Universidade Federal de Goias |
2008-09-30 |
| NCT00846092 |
Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study |
https://ClinicalTrials.gov/show/NCT00846092 |
Completed |
Medical College of Wisconsin |
2013-02-28 |
| NCT04234438 |
Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser |
https://ClinicalTrials.gov/show/NCT04234438 |
Completed |
Ankara Universitesi Teknokent |
2019-10-30 |
| NCT03821168 |
The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03821168 |
Recruiting |
Shahid Beheshti University of Medical Sciences |
2019-04-01 |
| NCT02181400 |
Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT02181400 |
Completed |
University of Sydney |
2019-02-15 |
| NCT01769352 |
Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1) |
https://ClinicalTrials.gov/show/NCT01769352 |
Completed |
Johns Hopkins University |
2016-04-30 |
| NCT01694212 |
Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT01694212 |
Completed |
Eye Clinic Medic Zuljan Jukic |
2016-10-31 |
| NCT00970957 |
Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00970957 |
Completed |
Instituto Universitario de OftalmobiologÃa Aplicada (Institute of Applied Ophthalmobiology) - IOBA |
2013-02-28 |
| NCT00826618 |
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema |
https://ClinicalTrials.gov/show/NCT00826618 |
Completed |
University of Miami |
2012-09-30 |
| NCT00901186 |
Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00901186 |
Completed |
Novartis |
2012-08-31 |
| NCT03908307 |
Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China |
https://ClinicalTrials.gov/show/NCT03908307 |
Recruiting |
Allergan |
2021-09-30 |
| NCT03598205 |
Curcumin and Intravitreal Dexamethasone in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03598205 |
Completed |
Fondazione G.B. Bietti, IRCCS |
2018-09-28 |
| NCT01783886 |
Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement |
https://ClinicalTrials.gov/show/NCT01783886 |
Completed |
Bayer |
2015-03-31 |
| NCT01552408 |
Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE) |
https://ClinicalTrials.gov/show/NCT01552408 |
Completed |
Greater Houston Retina Research |
2017-05-18 |
| NCT01273727 |
Ozurdex for Macular Edema Post Membrane Peeling |
https://ClinicalTrials.gov/show/NCT01273727 |
Completed |
Retina Specialists, PC |
2014-04-30 |
| NCT00815646 |
Prevention and Treatment of Immersion Pulmonary Edema |
https://ClinicalTrials.gov/show/NCT00815646 |
Completed |
Duke University |
2015-12-31 |
| NCT00815360 |
Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion |
https://ClinicalTrials.gov/show/NCT00815360 |
Completed |
Retina Associates of Florida, P.A. |
2011-07-31 |
| NCT01945866 |
Phase II Combination Steroid and Anti-VEGF for Persistent DME |
https://ClinicalTrials.gov/show/NCT01945866 |
Completed |
Jaeb Center for Health Research |
2017-06-05 |
| NCT01846299 |
To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema |
https://ClinicalTrials.gov/show/NCT01846299 |
Completed |
Novartis |
2015-09-30 |
| NCT03690050 |
A Comparison of Standard Laser With Micropulse Laser for the Treatment of Diabetic Macular Oedema. |
https://ClinicalTrials.gov/show/NCT03690050 |
Recruiting |
Belfast Health and Social Care Trust |
2020-12-31 |
| NCT00801866 |
Avastin for Post-Photocoagulation Macular Edema |
https://ClinicalTrials.gov/show/NCT00801866 |
Completed |
Asociación para Evitar la Ceguera en México |
NA |
| NCT02581995 |
Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME. |
https://ClinicalTrials.gov/show/NCT02581995 |
Completed |
Bayer |
2017-08-09 |
| NCT03866005 |
Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03866005 |
Recruiting |
ZeaVision, LLC |
2021-11-01 |
| NCT02460874 |
Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593) |
https://ClinicalTrials.gov/show/NCT02460874 |
Recruiting |
University of Alabama at Birmingham |
2021-03-31 |
| NCT01951066 |
Diabetic Macular Edema Treated With Ozurdex (DMEO) |
https://ClinicalTrials.gov/show/NCT01951066 |
Completed |
Johns Hopkins University |
2015-12-31 |
| NCT01471691 |
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab |
https://ClinicalTrials.gov/show/NCT01471691 |
Completed |
Hanscom, Thomas, M.D. |
2014-02-28 |
| NCT03941977 |
Treatment of Bone Marrow Edema Lesions of the Knee With Percutaneous Grafting |
https://ClinicalTrials.gov/show/NCT03941977 |
Completed |
University of Sao Paulo General Hospital |
2018-12-30 |
| NCT03610646 |
Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT03610646 |
Recruiting |
Mylan Inc. |
2020-02-28 |
| NCT00915837 |
Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00915837 |
Completed |
SurModics, Inc. |
2009-04-30 |
| NCT00785174 |
Non-Invasive Ventilation Versus Continuous Positive Airway Pressure in Cardiogenic Pulmonary Edema: a Multicentre Study |
https://ClinicalTrials.gov/show/NCT00785174 |
Completed |
University of Monastir |
2008-06-30 |
| NCT00790803 |
Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema |
https://ClinicalTrials.gov/show/NCT00790803 |
Completed |
Wake Forest University Health Sciences |
2011-11-30 |
| NCT00780780 |
Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00780780 |
Completed |
Federal University of São Paulo |
2008-08-31 |
| NCT00764244 |
Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00764244 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2009-12-31 |
| NCT00758628 |
Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema. |
https://ClinicalTrials.gov/show/NCT00758628 |
Completed |
Bp Consulting, Inc |
2009-05-31 |
| NCT00737971 |
Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00737971 |
Completed |
Federal University of São Paulo |
2012-12-31 |
| NCT00732719 |
Compression Device Safety Study on Edema |
https://ClinicalTrials.gov/show/NCT00732719 |
Completed |
ConvaTec Inc. |
2004-11-30 |
| NCT00683176 |
Effect of Choline Fenofibrate (SLV348) on Macular Edema |
https://ClinicalTrials.gov/show/NCT00683176 |
Completed |
Abbott |
2011-03-31 |
| NCT00687804 |
A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study |
https://ClinicalTrials.gov/show/NCT00687804 |
Completed |
Novartis |
2010-01-31 |
| NCT00687154 |
Observational Study of DME Following Scatter Laser Photocoagulation |
https://ClinicalTrials.gov/show/NCT00687154 |
Completed |
Jaeb Center for Health Research |
2008-01-31 |
| NCT00682539 |
Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00682539 |
Completed |
Medical University of Vienna |
2014-07-31 |
| NCT00665106 |
Safety and Tolerability of NOVA63035 “Corticosteroid” in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00665106 |
Completed |
Santen SAS |
2011-09-30 |
| NCT00656643 |
Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00656643 |
Completed |
Santen Inc. |
2009-11-30 |
| NCT00627770 |
Lower Leg Edema Evaluation After Total Knee Arthroplasty Using Bioimpedance |
https://ClinicalTrials.gov/show/NCT00627770 |
Completed |
Haute Ecole de Santé Vaud |
2008-11-30 |
| NCT00605280 |
A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension. |
https://ClinicalTrials.gov/show/NCT00605280 |
Completed |
Pfizer |
2009-11-30 |
| NCT00604227 |
Pulmonary Function at High-Altitude |
https://ClinicalTrials.gov/show/NCT00604227 |
Completed |
Heidelberg University |
NA |
| NCT00595543 |
Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5% |
https://ClinicalTrials.gov/show/NCT00595543 |
Completed |
Bp Consulting, Inc |
2009-03-31 |
| NCT00593190 |
Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus |
https://ClinicalTrials.gov/show/NCT00593190 |
Completed |
HaEmek Medical Center, Israel |
2008-12-31 |
| NCT00562406 |
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) |
https://ClinicalTrials.gov/show/NCT00562406 |
Completed |
Klinikum Ludwigshafen |
2010-09-30 |
| NCT00576459 |
Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00576459 |
Completed |
Bausch & Lomb Incorporated |
2006-06-30 |
| NCT00567697 |
A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO |
https://ClinicalTrials.gov/show/NCT00567697 |
Completed |
Aleris Helse |
2008-10-31 |
| NCT00559442 |
Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction |
https://ClinicalTrials.gov/show/NCT00559442 |
Completed |
Heidelberg University |
2010-12-31 |
| NCT00554580 |
Continuous Positive Airway Pressure for Acute Pulmonary Edema |
https://ClinicalTrials.gov/show/NCT00554580 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2008-07-31 |
| NCT00544869 |
A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure) |
https://ClinicalTrials.gov/show/NCT00544869 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2009-02-28 |
| NCT00536692 |
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT00536692 |
Completed |
CoMentis |
NA |
| NCT00525265 |
A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure) |
https://ClinicalTrials.gov/show/NCT00525265 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2009-01-31 |
| NCT00502541 |
Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00502541 |
Completed |
Bausch & Lomb Incorporated |
2006-09-30 |
| NCT00498355 |
Lucentis for Inflammatory Macular Edema Trial |
https://ClinicalTrials.gov/show/NCT00498355 |
Completed |
University of California, San Francisco |
2009-01-31 |
| NCT00496405 |
Unilateral Bevacizumab for Bilateral Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00496405 |
Completed |
Asociación para Evitar la Ceguera en México |
NA |
| NCT00494494 |
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery |
https://ClinicalTrials.gov/show/NCT00494494 |
Completed |
University of North Carolina, Chapel Hill |
2008-04-30 |
| NCT00490815 |
Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00490815 |
Completed |
Alimera Sciences |
2009-09-30 |
| NCT00486018 |
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) |
https://ClinicalTrials.gov/show/NCT00486018 |
Completed |
Genentech, Inc. |
2009-05-31 |
| NCT00485836 |
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE) |
https://ClinicalTrials.gov/show/NCT00485836 |
Completed |
Genentech, Inc. |
2009-06-30 |
| NCT00473382 |
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE) |
https://ClinicalTrials.gov/show/NCT00473382 |
Completed |
Genentech, Inc. |
2011-01-31 |
| NCT00473330 |
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) |
https://ClinicalTrials.gov/show/NCT00473330 |
Completed |
Genentech, Inc. |
2010-11-30 |
| NCT00469781 |
Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening |
https://ClinicalTrials.gov/show/NCT00469781 |
Completed |
Center For Excellence In Eye Care |
2008-09-30 |
| NCT00464685 |
Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00464685 |
Completed |
Allergan |
2010-02-08 |
| NCT00462670 |
A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure) |
https://ClinicalTrials.gov/show/NCT00462670 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2008-10-31 |
| NCT00453947 |
Non-Invasive Ventilation in Pulmonary Edema |
https://ClinicalTrials.gov/show/NCT00453947 |
Completed |
Ospedale S. Giovanni Bosco |
NA |
| NCT00446381 |
Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) |
https://ClinicalTrials.gov/show/NCT00446381 |
Completed |
Lawson Health Research Institute |
2008-09-30 |
| NCT00444600 |
Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00444600 |
Completed |
Jaeb Center for Health Research |
2009-12-31 |
| NCT00440609 |
Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00440609 |
Completed |
Long Island Vitreoretinal Consultants |
2012-11-30 |
| NCT00412451 |
A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) |
https://ClinicalTrials.gov/show/NCT00412451 |
Completed |
ThromboGenics |
2010-01-31 |
| NCT00407381 |
The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study |
https://ClinicalTrials.gov/show/NCT00407381 |
Completed |
Johns Hopkins University |
2010-08-31 |
| NCT00407355 |
Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions |
https://ClinicalTrials.gov/show/NCT00407355 |
Completed |
Johns Hopkins University |
2013-02-28 |
| NCT00401115 |
Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00401115 |
Completed |
Santen Inc. |
2008-06-30 |
| NCT00390442 |
Out-of-Hospital CPAP for Severe Cardiogenic Pulmonary Edema |
https://ClinicalTrials.gov/show/NCT00390442 |
Completed |
Hopital Lariboisière |
NA |
| NCT00387582 |
Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00387582 |
Completed |
Rocky Mountain Retina Consultants |
2009-02-28 |
| NCT00371410 |
Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00371410 |
Completed |
Samsung Medical Center |
NA |
| NCT00369863 |
A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00369863 |
Completed |
Shahid Beheshti University of Medical Sciences |
NA |
| NCT00369486 |
A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00369486 |
Completed |
Jaeb Center for Health Research |
2006-06-30 |
| NCT00367133 |
Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00367133 |
Completed |
Jaeb Center for Health Research |
2008-05-31 |
| NCT00346138 |
A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema |
https://ClinicalTrials.gov/show/NCT00346138 |
Completed |
Mayo Clinic |
2009-06-30 |
| NCT00344968 |
Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00344968 |
Completed |
Alimera Sciences |
2009-12-31 |
| NCT00333671 |
Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema) |
https://ClinicalTrials.gov/show/NCT00333671 |
Completed |
Glostrup University Hospital, Copenhagen |
2006-02-28 |
| NCT00320814 |
Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00320814 |
Completed |
Regeneron Pharmaceuticals |
2006-08-31 |
| NCT00308542 |
A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00308542 |
Completed |
Sanwa Kagaku Kenkyusho Co., Ltd. |
NA |
| NCT00308477 |
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00308477 |
Completed |
Sanwa Kagaku Kenkyusho Co., Ltd. |
NA |
| NCT00306904 |
Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00306904 |
Completed |
OPKO Health, Inc. |
2007-09-30 |
| NCT00284050 |
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement |
https://ClinicalTrials.gov/show/NCT00284050 |
Completed |
Novartis |
2008-06-30 |
| NCT00280826 |
Efalizumab to Treat Uveitis |
https://ClinicalTrials.gov/show/NCT00280826 |
Completed |
National Institutes of Health Clinical Center (CC) |
2009-02-28 |
| NCT00274430 |
Prevention of High Altitude Pulmonary Edema |
https://ClinicalTrials.gov/show/NCT00274430 |
Completed |
University of Zurich |
NA |
| NCT00234104 |
A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure) |
https://ClinicalTrials.gov/show/NCT00234104 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2006-01-31 |
| NCT00229931 |
Triamcinolone vs. Laser for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00229931 |
Completed |
University of Oklahoma |
2013-05-31 |
| NCT00213681 |
CPAP Versus Bilevel Pressure Support Ventilation in Cardiogenic Pulmonary Edema |
https://ClinicalTrials.gov/show/NCT00213681 |
Completed |
University Hospital, Rouen |
NA |
| NCT00167518 |
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO) |
https://ClinicalTrials.gov/show/NCT00167518 |
Completed |
University of Sydney |
NA |
| NCT00199576 |
Prevention of Post-Extubation Laryngeal Edema With Intravenous Corticosteroids |
https://ClinicalTrials.gov/show/NCT00199576 |
Completed |
University Hospital, Limoges |
NA |
| NCT00168389 |
A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00168389 |
Completed |
Allergan |
2012-06-30 |
| NCT00168324 |
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00168324 |
Completed |
Allergan |
2008-03-01 |
| NCT00168298 |
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00168298 |
Completed |
Allergan |
2008-03-01 |
| NCT00168337 |
A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00168337 |
Completed |
Allergan |
2012-05-31 |
| NCT00133952 |
Effect of Ruboxistaurin on Clinically Significant Macular Edema |
https://ClinicalTrials.gov/show/NCT00133952 |
Completed |
Chromaderm, Inc. |
2011-07-31 |
| NCT00148330 |
Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study |
https://ClinicalTrials.gov/show/NCT00148330 |
Completed |
University of Sydney |
2008-07-31 |
| NCT00148265 |
A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema |
https://ClinicalTrials.gov/show/NCT00148265 |
Completed |
University of Sydney |
2009-05-31 |
| NCT00105027 |
The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study |
https://ClinicalTrials.gov/show/NCT00105027 |
Completed |
The Emmes Company, LLC |
2009-02-28 |
| NCT00137228 |
Measuring Hand Edema in Burn Patients |
https://ClinicalTrials.gov/show/NCT00137228 |
Completed |
United States Army Institute of Surgical Research |
NA |
| NCT00106132 |
Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage |
https://ClinicalTrials.gov/show/NCT00106132 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00105404 |
Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation |
https://ClinicalTrials.gov/show/NCT00105404 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00088166 |
XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors |
https://ClinicalTrials.gov/show/NCT00088166 |
Completed |
Celtic Pharma Development Services |
2008-03-31 |
| NCT00055042 |
Laser and Antioxidant Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00055042 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00027287 |
Laser and Medical Treatment of Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00027287 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00035906 |
Research Study in Patients With Persistent Macular Edema |
https://ClinicalTrials.gov/show/NCT00035906 |
Completed |
Allergan |
2004-08-31 |
| NCT00021645 |
Vitamin E to Treat Uveitis-Associated Macular Edema |
https://ClinicalTrials.gov/show/NCT00021645 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00071773 |
A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT00071773 |
Completed |
Jaeb Center for Health Research |
2005-11-30 |
| NCT00532220 |
Study Into the Effect of Ibandronate for the Treatment of Bone Marrow Edema in Relation to Spontaneous or Non-traumatic Osteonecrosis of the Knee: A Randomized Double-blind, Placebo-controlled Trial |
https://ClinicalTrials.gov/show/NCT00532220 |
Completed |
University Hospital, Basel, Switzerland |
2015-08-31 |
| NCT00000115 |
Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema |
https://ClinicalTrials.gov/show/NCT00000115 |
Completed |
National Eye Institute (NEI) |
NA |